Thank you to everyone who attended our webinar ‘Antibodies to watch in 2026‘ in association with the journal, mAbs. Below are ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

French regulators have authorised the first specific antidote for ricin, a toxin viewed as a serious bioterrorism threat with no prior targeted treatment.

Rapid Novor Inc., the world's leader in mass spectrometry (MS)-based antibody sequencing, published a peer-reviewed research article where REpAb ® antibody discovery platform was used to sequence a ...

ADMA Biologics ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases. ADMA’s lead product, Asceniv, is a plasma-derived ...